0
ARTICLE |

Global Strategies for the Control of Rheumatic Fever FREE

Gene H. Stollerman, MD
[+] Author Affiliations

Address editorial communications to the Editor, 535 N Dearborn St, Chicago, IL 60610.


JAMA. 1983;249(7):931-931. doi:10.1001/jama.1983.03330310061031
Text Size: A A A
Published online

The global disparities in the prevalence of rheumatic fever1 are a vivid reminder of the relation of high standards of housing and health care to control of the disease. Rheumatic fever still ranks as a major health problem in large segments of the populations of Asia, Africa, and South America.2 In fact, the industrialization of some native or aboriginal Third World populations has resulted in an alarming prevalence of rheumatic fever, estimated to be increasing in some provinces of South Africa.2-4 These estimates actually exceed rheumatic fever incidence rates of 61/100,000 per year calculated for Manhattan schoolchildren between 1963 and 1965, a time when the disease's incidence was already declining rapidly in the United States. In this issue of JAMA (p 895), Land and Bisno report their conscientious effort to determine the incidence of acute rheumatic fever in Memphis-Shelby County, Tennessee, for the years 1977 through 1981.

REFERENCES

Stollerman GH:  Global changes in group A streptococcal diseases and strategies for their prevention . Adv Intern Med 1981;;27:373-406.
 Community control of rheumatic heart disease in developing countries: Strategies for prevention and control . WHO Chron 1980;;34:389.
Winship WS: Rheumatic fever: A South African profile, symposium on cardiology in a tropical environment. South African Medical Research Council, Durban, South Africa, Sept 1-3, 1982 , pp 171-174.
Bundred PE: Epidemiology of Rheumatic Heart Disease in South Africa , abstract 12. Cape Town, South Africa, South African Cardiac Congress, (Sept 6) -8, 1982, in press.
Colling A, Kerr I, Maxted WR, et al:  Minimum amount of penicillin prophylaxis required to control Streptococcus pyogenes epidemic in closed community . Br Med J 1982;;285:95.
Bisno AL, Berrios X, Quesney F, et al:  Type-specific antibodies to structurally-defined fragments of streptococcal M proteins in patients with acute rheumatic fever . Infect Immun 1982;;38:573-579.
Bisno AL:  The concept of rheumatogenic and non-rheumatogenic group A streptococci , in Read SE, Zabrichie JB (eds): Streptococcal Diseases and the Immune Response . New York, Academic Press Inc, 1980;, pp 789-803.
Beachey EH, Dale JB, Simpson WA, et al:  Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein . Nature 1981;;292:457-459.
Hasty DL, Beachey EH, Simpson WA, et al:  Hybridoma antibodies against protective and nonprotective antigenic determinants of a structurally defined polypeptide fragment of streptococcal M protein . J Exp Med 1982;;155:1010-1018.
Bayes T, cited by Weinstein MC, Fineberg HV: Clinical Decision Analysis . Philadelphia, WB Saunders Co, 1980;, pp 92-94.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Stollerman GH:  Global changes in group A streptococcal diseases and strategies for their prevention . Adv Intern Med 1981;;27:373-406.
 Community control of rheumatic heart disease in developing countries: Strategies for prevention and control . WHO Chron 1980;;34:389.
Winship WS: Rheumatic fever: A South African profile, symposium on cardiology in a tropical environment. South African Medical Research Council, Durban, South Africa, Sept 1-3, 1982 , pp 171-174.
Bundred PE: Epidemiology of Rheumatic Heart Disease in South Africa , abstract 12. Cape Town, South Africa, South African Cardiac Congress, (Sept 6) -8, 1982, in press.
Colling A, Kerr I, Maxted WR, et al:  Minimum amount of penicillin prophylaxis required to control Streptococcus pyogenes epidemic in closed community . Br Med J 1982;;285:95.
Bisno AL, Berrios X, Quesney F, et al:  Type-specific antibodies to structurally-defined fragments of streptococcal M proteins in patients with acute rheumatic fever . Infect Immun 1982;;38:573-579.
Bisno AL:  The concept of rheumatogenic and non-rheumatogenic group A streptococci , in Read SE, Zabrichie JB (eds): Streptococcal Diseases and the Immune Response . New York, Academic Press Inc, 1980;, pp 789-803.
Beachey EH, Dale JB, Simpson WA, et al:  Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein . Nature 1981;;292:457-459.
Hasty DL, Beachey EH, Simpson WA, et al:  Hybridoma antibodies against protective and nonprotective antigenic determinants of a structurally defined polypeptide fragment of streptococcal M protein . J Exp Med 1982;;155:1010-1018.
Bayes T, cited by Weinstein MC, Fineberg HV: Clinical Decision Analysis . Philadelphia, WB Saunders Co, 1980;, pp 92-94.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.